About Tarsons
Products IPO
Incorporated in 1983, Tarsons Products Ltd. is one of the leading
life sciences companies involved in the manufacturing and supplying of labware
products. The company comes with a highly diversified product portfolio,
including lab consumables, reusable products and more.
Products manufactured in Tarsons are widely used across hospitals,
diagnostic labs, academic institutions, pharmaceutical companies and more.
Tarsons Products currently has 5 manufacturing facilities in West
Bengal, sprawling over 20,000 square metres. As of 31 March 2021, the company
has a product portfolio with more than 1,700 SKUs for 300 products.
The company has a robust distribution network throughout India,
with more than 141 authorized distributors. Moreover, it supplies its products
to more than 40 countries.
Tarsons
Products IPO: Objectives
Tarsons Products intends to use the proceeds from its public
offering for the following purposes:
- To
fund a portion of the capital expenditure that is required for the
expansion of its facility in Panchla, West Bengal
- To
either repay or prepay its borrowings
- For
general corporate expenses
Tarsons Products IPO - Details
Tarsons Products filed
its DRHP with market regulator SEBI for its IPO on 10 August 2021. The initial
public offering of Tarsons Products will include a fresh issuance of shares
worth Rs. 150 crores and an offer for sale of 1.32 crores shares by the
existing investors and promoters.
The offer for sale
will include the offloading of 3.9 lakhs shares by Sanjive Sehgal, and 3.1 lakhs
share sale by Rohan Sehgal. Apart from this, Clear Vision Investment Holdings
Pvt. Ltd. is set to release around 1.25 crores shares. Tarsons Products IPO
will also include a reservation for company employees.
The key details of
Tarsons Products IPO are shown in the following tabular representation:
Opening Date: Nov 15, 2021
Closing Date: Nov 17, 2021
Price Band: ₹635 to ₹662 per equity share
Issue Size: ₹1,023.47 Cr
Face Value: ₹ 2 per equity share
Market Lot: 22 Shares
Listing at NSE, BSE
Tarsons Products IPO
Important Dates
IPO Open Date |
15 November 2021 |
IPO
Close Date |
17 November 2021 |
Date For
Basis Of Allotment |
23 November 2021 |
Initiation
Of Refunds |
24 November 2021 |
Credit
Of Shares To |
26 November 2021 |
Why Should You Invest in Tarsons Products IPO?
Here are some of the
key reasons why Tarsons Products is an ideal investment option: –
- Tarsons Products is one of the top life sciences
companies engaged in manufacturing a wide range of lab components. The company
is known for its high-quality goods and excellent brand awareness.
- The company comes with a massive client base,
including some of the reputed Indian institutions such as Dr. Reddy’s
Laboratories, Indian Institute of Chemical Technology, Metropolis
Healthcare, Dr. Lal Path Labs, Enzene Biosciences, National Centre for
Biological Sciences, and more.
- Tarsons Products has a robust sales and
distribution network across the country. It also supplies its products to
major international markets.
- The company comes with impressive financials
with strong assets, revenue generation and profit.
Financial Highlights
Financial
Year |
Total
Assets |
Total
Revenue |
Profit
After Tax |
30 June 2021 |
Rs. 3,647.74 |
Rs. 711.27 |
Rs. 248.35 |
31
March 2021 |
Rs. 2,959.50 |
Rs. 2,342.91 |
Rs. 688.70 |
30 June 2020 |
Rs. 2,356.57 |
Rs. 435.73 |
Rs. 69.68 |
31
March 2020 |
Rs. 2,487.06 |
Rs. 1,800.54 |
Rs. 405.31 |
31 March 2019 |
Rs. 2,119.58 |
Rs. 1,847.19 |
Rs. 389.58 |
**Note: Amount is in
millions
Tarsons Products IPO – Noteworthy Highlights
The following section
consists of some crucial highlights about Tarsons Products that prospective
investors should be aware of:
1. The company boasts
of having 5 well-equipped manufacturing facilities that are vertically
integrated and come with automation facilities. This helps the company to
maintain quality while cutting costs.
2. For the financial
year ending on 31 March 2021, Tarsons Products registered a 23.67% growth in
its net worth along with a 49.36% jump in EBITDA.
3. The total asset of
Tarsons Products climbed by 19% during the last financial year.
4. Some of its
products, such as cryovials, macro tips, micro tips, and centrifuge tubes, have
received CE-IVD certification.
5. The company exports
its lab products to more than 40 countries.
6. Tarsons Products
come with operating revenue that ranges between Rs. 100-Rs. 500 crores for the
financial year that ended on 31 March 2021.
Tarsons Products IPO - SWOT Analysis
Strengths
- Diverse product
portfolio: Tarsons
Products manufactures and supplies a diverse range of labware components
which are broadly classified into consumables, reusable and other products.
The consumable product section includes cryogenic ware, petri dish, PCR consumables transfer pipettes and more. In the reusable segments, the company manufactures bottles, beakers, carboys and more. It also produces vortex shakers, centrifuges and other benchtop instruments. These products are supplied to numerous reputed hospitals, diagnostic centres and national institutions. - Addresses a Large
Market: The labware market is
witnessing massive growth in India fueled by increased investment, growing
awareness for health issues, and enormous growth in the health sector.
Tarsons addresses a major domestic and international market and maintains
long-term connections with its customers and clients.
- Strong Management
Team: Founded in 1983, Tarsons
Products is backed by highly experienced promoters and a powerful
management team. This has enabled the company to bolster its presence in
the Indian labware market.
- Strong Financial
Performance: Tarsons has
been able to post improved financial performance due to cost-cutting and
higher profitability. The company's revenue and profit have been on a
steady rise for the past three years. Its long-term and current borrowings
have also come down recently.
Weaknesses
- Cost Overrun or
Implementation Delay: The
company has five facilities and is planning to build another one.
Moreover, it would be working on expanding all the existing facilities.
Considering the capacity of the expansion plan, Tarsons might be facing
implementation delays or cost overruns.
- Geographical
Concentration of Manufacturing Units: All of the manufacturing units of Tarsons
Products are located in West Bengal. Around 86.32% of the manufacturing
revenue comes from the units located at Dhulagarh and Jangalpur. Such
concentration of manufacturing might affect business operations and
finances.
- Pending Land
Approval at one of the Facilities: The manufacturing facility at Jangalpur is
situated on a plot for which the company is yet to receive complete
approval. Delay in approval might lead to regulatory actions in the
future.
Opportunities
- Expansion of
Client Base: The
healthcare sector of the country will see significant growth as
investments are set to increase. Consequently, the demand for lab
consumables and reusable products would jump, leading to a potential
expansion of the labware market. Tarsons already has an impressive list of
reputed clients. However, it has the potential to expand its client base
with rising demand.
Threats
- Rise in Inflation: Inflation rates have been quite volatile
in recent years. If inflation rises in the upcoming days, it will lead to
increased expenses and reduced revenue generation. This can adversely
impact the business prospects and finances of the company.
- Impact of the
Pandemic: Although the COVID-19 pandemic
has subdued in recent months, the threat still remains. The new virus
variants might spark off COVID-19 waves, which can significantly affect
the business.
Competitor Analysis: Tarsons Products
Tarsons
Products is one of the most notable labware manufacturers in the country, with
presence in over 40 countries. Here is a brief overview of some of the
prominent competitors of Tarsons Products:
Competitor |
Revenue |
Innova Corporate |
$17 Million |
Acumen Labware |
$5 Million |
BrandTech Scientific
Inc. |
$5-$9.9 Million |
PlastX |
$5 Million |
Jensen Inert
Products |
$1- $4.9 Million |
How to Apply for
Tarsons Products IPO?
You
can apply for the Tarsons Products IPO in these ways:
Demat Account
If you’re a new
investor open demat account for free with Angel One using link https://tinyurl.com/k79bdf4z to begin your investment journey.
UPI
Alternatively, you can apply for Tarsons Products IPO through UPI. First, you
need to connect your bank account with a preferred UPI platform. Then, link it
with your Angel One account. After that, you can use the UPI option present on
the Angel One website and app to subscribe to Tarsons Products IPO.
Finally, go to the UPI app to book shares for the IPO.
. #tarsonsproductsipo
#tarsonsipo
#ipo
#ipoalert
No comments:
Post a Comment